Neurology, Neuropsychiatry, Psychosomatics

Advanced search


Order results by:     
Issue Title
Vol 4, No 2 (2012) Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease Abstract  similar documents
S N Illarioshkin
"... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..."
Vol 4, No 1 (2012) Sustained-release pramipexole in the treatment of Parkinson’s disease Abstract  similar documents
Natalia Vladimirovna Fedorova
"... for dopaminergic deficiency in Parkinson’s disease (PD). Since 1996, pramipexole has been used to treat early ..."
Vol 6, No 3 (2014) Current therapy for Parkinson's disease Abstract  similar documents
A. V. Obukhova
"... in the nigrostriatal system. Levodopa preparations and dopamine receptor agonists (DRAs) that are prescribed ..."
Vol 3, No 4 (2011) Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole Abstract  similar documents
M. R. Nodel
"... pramipexole (Mirapex). Patients and methods. Sixty patients with PD (disease duration 6.02±3.47 years; stage ..."
Vol 3, No 1 (2011) Sleep disorders in Parkinson's disease Abstract  similar documents
M. R. Nodel
"... 63.2±9.9 years; mean PD duration 6.5±4.2 years) were followed up. Forty patients received pramipexole ..."
Vol 6, No 1 (2014) Apathy in Parkinson's disease patients Abstract  similar documents
M. R. Nodel
"... to the Hoehn and Yahr scale, 2.5) received pramipexole (1.5–3.0 mg/day) to correct motor disorders ..."
Vol 4, No 3 (2012) Clinical experience with requip modutab Abstract  similar documents
Denis Valeryevich Zakharov, V A Mikhailov
"... The efficacy of dopamine receptor agonists (DRAs) is determined by a number of advantages. DRAs ..."
Vol 5, No 1 (2013) Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease Abstract  similar documents
Oleg Semenovich Levin, V K Datiyeva
"... receptor agonist (DRAs), which has been widely used to treat Parkinson’s disease (PD) in foreign countries ..."
Vol 5, No 3 (2013) The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease Abstract  similar documents
Marina Romanovna Nodel
"... Rotigotine is a new, non-ergot dopamine receptor agonist (DRA) formulated as a transdermal drug ..."
Vol 8, No 2 (2016) Effectiveness of prolonged-release melatonin in Improving Quality of Sleep in Patients Aged 55 or Over Abstract  similar documents
G. V. Kovrov, M. V. Agaltsov, Z. N. Sukmarova
"... Цель исследования – оценка эффективности препарата мелатонина пролонгированного высвобождения ..."
Vol 2, No 2 (2010) Antiaggregant therapy in neurological practice: objectives and possibilities Abstract  similar documents
E. V. Portnyagina, A. F. Portnyagin
Vol 2, No 3 (2010) Russian observational study of the efficacy and tolerability of depakine chrono as first-line monotherapy for focal epilepsy Abstract  similar documents
E. D. Belousova
Vol 9, No 3 (2017) Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation Abstract  similar documents
P. N. Vlasov
"... терапии. Фармакологические технологии, обеспечивающие замедленное высвобождение активного вещества ..."
Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches Abstract  similar documents
P. N. Vlasov, N. V. Orekhova, M. V. Antonyuk, N. V. Filatova, N. A. Schnaider, D. V. Dmitrenko, S. N. Zobova, I. E. Poverennova, A. V. Yakunina, V. A. Kalinin, S. K. Zyryanov, I. F. Tishchenkova
Vol 4, No 2 (2012) Therapy for back pain syndrome Abstract  similar documents
E Yu Solovyeva
"... замедленным высвобождением и отдельные гранулы витаминов В 1, В 6, В ..."
Vol 9, No 2 (2017) Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, L. V. Stakhovskaya, L. E. Fedotova
"... дофамина, усиливать высвобождение ацетилхолина в нейронах. Эти молекулярные эффекты соответствуют ..."
Vol 4, No 1 (2012) Generalized epilepsies: current conceptions and therapeutic approaches Abstract  similar documents
L R Zenkov
"... контролированным высвобождением действующего вещества — Депакин хроно и Депакин хроносфера. Рассматриваются ..."
Vol 2, No 4 (2010) Gastrointestinal events during treatment with nonsteroidal anti-inflammatory drugs (according to the data of the CONDOR study) Abstract  similar documents
V. V. Alekseev
"... дозе 200 мг 2 раза в день, и группа пациентов, которым был назначен диклофенак медленного высвобождения ..."
1 - 18 of 18 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)